Literature DB >> 2717761

Experimental lymph node metastases: enhanced detection with MR lymphography.

R Weissleder1, G Elizondo, L Josephson, C C Compton, C J Fretz, D D Stark, J T Ferrucci.   

Abstract

Magnetic resonance (MR) lymphography with superparamagnetic iron oxide (AMI-25) as a contrast agent was developed in an animal model with tumor-bearing lymph nodes. After interstitial administration of 20 mumol of iron per kilogram of body weight into the footpads of rats, the T2 of popliteal and paraaortic lymph nodes decreased from 67 msec +/- 8.2 to 9.5 msec +/- 0.9 and 9.3 msec +/- 0.9, respectively. T2 relaxation times of lymph nodes containing metastases showed a significantly higher value (61 msec +/- 6.2, P less than .005) after interstitial administration of the contrast agent. Intravenous administration of AMI-25 did not produce enhancement of normal or metastatic lymph node relaxation times. The signal intensity of normal lymph nodes decreased profoundly on spin-echo MR images (repetition time of 500 msec, echo time of 30 msec) after interstitial administration, whereas lymph nodes with metastases showed no significant change in signal intensity. Experimental results indicate that MR lymphography may potentially increase the sensitivity of MR imaging the detection of lymphatic malignancy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2717761     DOI: 10.1148/radiology.171.3.2717761

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

1.  Gadofluorine 8: initial experience with a new contrast medium for interstitial MR lymphography.

Authors:  B Misselwitz; J Platzek; B Radüchel; J J Oellinger; H J Weinmann
Journal:  MAGMA       Date:  1999-08       Impact factor: 2.310

Review 2.  Imaging the lymphatic system: possibilities and clinical applications.

Authors:  Olivier Clément; Alain Luciani
Journal:  Eur Radiol       Date:  2004-03-09       Impact factor: 5.315

Review 3.  Review on photoacoustic imaging of the brain using nanoprobes.

Authors:  Depeng Wang; Yun Wu; Jun Xia
Journal:  Neurophotonics       Date:  2016-01-04       Impact factor: 3.593

4.  Labeling fibroblasts with biotin-BSA-GdDTPA-FAM for tracking of tumor-associated stroma by fluorescence and MR imaging.

Authors:  D Granot; L A Kunz-Schughart; M Neeman
Journal:  Magn Reson Med       Date:  2005-10       Impact factor: 4.668

5.  Diagnostic significance of magnetic resonance imaging in preoperative evaluation of patients with laryngeal tumors.

Authors:  Bojan Banko; Vojko Dukić; Jovica Milovanović; Jelena Dokić Kovač; Vera Artiko; Ružica Maksimović
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-12       Impact factor: 2.503

Review 6.  Molecular magnetic resonance contrast agents for the detection of cancer: past and present.

Authors:  Alexei Bogdanov; Mary L Mazzanti
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

7.  Synergistic enhancement of iron oxide nanoparticle and gadolinium for dual-contrast MRI.

Authors:  Fan Zhang; Xinglu Huang; Chunqi Qian; Lei Zhu; Naoki Hida; Gang Niu; Xiaoyuan Chen
Journal:  Biochem Biophys Res Commun       Date:  2012-08-07       Impact factor: 3.575

Review 8.  Contrast-enhanced MR imaging of lymph nodes in cancer patients.

Authors:  Seung Hong Choi; Woo Kyung Moon
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

9.  Differentiation of reactive and tumor metastatic lymph nodes with diffusion-weighted and SPIO-enhanced MRI.

Authors:  Fan Zhang; Lei Zhu; Xinglu Huang; Gang Niu; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2013-02       Impact factor: 3.488

Review 10.  MR - eyes for cancer: looking within an impenetrable disease.

Authors:  Marie-France Penet; Dmitri Artemov; Keyvan Farahani; Zaver M Bhujwalla
Journal:  NMR Biomed       Date:  2013-07       Impact factor: 4.044

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.